CRIS Current Research Information System

NANNI, CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.040
AS - Asia 3.763
EU - Europa 3.045
AF - Africa 196
SA - Sud America 192
OC - Oceania 4
Continente sconosciuto - Info sul continente non disponibili 2
Totale 12.242
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.995
VN - Vietnam 1.201
SG - Singapore 980
CN - Cina 921
GB - Regno Unito 844
SE - Svezia 443
DE - Germania 411
IT - Italia 331
UA - Ucraina 223
FR - Francia 207
HK - Hong Kong 207
RU - Federazione Russa 177
IN - India 158
BR - Brasile 142
IE - Irlanda 108
ZA - Sudafrica 76
EE - Estonia 75
JP - Giappone 59
CH - Svizzera 57
BD - Bangladesh 53
FI - Finlandia 50
TG - Togo 42
KR - Corea 33
NL - Olanda 28
AR - Argentina 27
CA - Canada 27
CI - Costa d'Avorio 25
SC - Seychelles 23
JO - Giordania 22
PH - Filippine 22
BE - Belgio 19
BG - Bulgaria 19
NG - Nigeria 15
IQ - Iraq 14
PL - Polonia 14
TR - Turchia 13
IR - Iran 12
GR - Grecia 11
ID - Indonesia 10
MX - Messico 10
TH - Thailandia 10
SA - Arabia Saudita 9
TW - Taiwan 8
PK - Pakistan 7
AT - Austria 6
EC - Ecuador 6
LB - Libano 6
CL - Cile 5
CZ - Repubblica Ceca 5
ES - Italia 5
RO - Romania 5
CO - Colombia 4
MA - Marocco 4
VE - Venezuela 4
AU - Australia 3
BJ - Benin 3
MY - Malesia 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
BO - Bolivia 2
DO - Repubblica Dominicana 2
HU - Ungheria 2
IL - Israele 2
JM - Giamaica 2
KE - Kenya 2
MU - Mauritius 2
NP - Nepal 2
PS - Palestinian Territory 2
TT - Trinidad e Tobago 2
AZ - Azerbaigian 1
BB - Barbados 1
CG - Congo 1
CM - Camerun 1
CR - Costa Rica 1
CY - Cipro 1
DZ - Algeria 1
HR - Croazia 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LT - Lituania 1
MD - Moldavia 1
ME - Montenegro 1
PE - Perù 1
PT - Portogallo 1
TN - Tunisia 1
TV - Tuvalu 1
UY - Uruguay 1
Totale 12.242
Salva come PNG Salva come JPEG
Città #
Southend 749
Singapore 655
Fairfield 552
Ashburn 493
Chandler 344
Houston 292
Wilmington 260
Seattle 243
Woodbridge 240
San Jose 206
Cambridge 202
Hong Kong 200
Dong Ket 175
Princeton 169
Ann Arbor 166
Santa Clara 154
Jacksonville 149
Ho Chi Minh City 147
Hanoi 132
Beijing 121
Boardman 119
Dublin 108
Nanjing 80
Padova 78
Westminster 78
Lauterbourg 71
Los Angeles 60
Bologna 56
Dallas 51
Tokyo 51
Bern 50
Helsinki 49
Jinan 48
New York 48
Shenyang 48
Berlin 46
Hefei 44
Council Bluffs 43
Lomé 42
Changsha 40
Saint Petersburg 39
Buffalo 34
Mülheim 34
Hebei 32
Nanchang 32
San Diego 31
Milan 30
Guangzhou 27
Bremen 26
Abidjan 25
Da Nang 25
Haiphong 25
Frankfurt am Main 23
Amman 22
Dearborn 21
Redondo Beach 21
Turin 21
Seoul 20
Haikou 19
Mahé 19
Sofia 19
São Paulo 19
Tianjin 19
Jiaxing 18
Brussels 16
Medford 15
Zhengzhou 15
Abeokuta 14
Falkenstein 14
The Dalles 14
Des Moines 13
Hangzhou 13
Redwood City 12
Warsaw 12
Falls Church 11
Kunming 11
Phoenix 11
Shanghai 11
Yubileyny 11
Florence 10
Baghdad 9
Biên Hòa 9
Brooklyn 9
Ningbo 9
Olalla 9
Paris 9
Taizhou 9
Wuhan 9
Atlanta 8
Can Tho 8
Düsseldorf 8
Norwalk 8
Rome 8
Taiyuan 8
Bühl 7
Chengdu 7
Columbus 7
Lanzhou 7
Mountain View 7
Ninh Bình 7
Totale 7.825
Salva come PNG Salva come JPEG
Nome #
CB(1) signaling in forebrain and sympathetic neurons is a key determinant of endocannabinoid actions on energy balance. 254
11C-mHED for PET / CT: principles of synthesis, methodology and first clinical applications 251
Positron emission tomography with computed tomography-based diagnosis of massive extramedullary progression in a patient with high-risk multiple myeloma. 247
Combined computed tomography and fluorodeoxyglucose positron emission tomography in the diagnosis of prosthetic valve endocarditis: A case series 238
A review discussing fluciclovine (18F) PET/CT imaging in the detection of recurrent prostate cancer 228
68Ga-DOTANOC PET/CT allows somatostatin receptor imaging in idiopathic pulmonary fibrosis: preliminary results. 227
Does the etiology of cardiac amyloidosis determine the myocardial uptake of [18F]-NaF PET/CT? 226
(68)Ga-DOTA-NOC PET/CT in comparison with CT for the detection of bone metastasis in patients with neuroendocrine tumours. 225
A novel model of CCl4-induced cirrosi with ascites in the mouse. 225
18F-FACBC COMPARED WITH 11C-CHOLINE PET/CT IN PATIENTS WITH BIOCHEMICAL RELAPSE AFTER RADICAL PROSTATECTOMY: A PROSPECTIVE STUDY IN 79 PATIENTS 210
Role of 18F-FDG PET/CT in the diagnosis of infective endocarditis in patients with an implanted cardiac device: A prospective study 209
68Ga-DOTANOC PET/CT Clinical Impact in Patients with Neuroendocrine Tumors. 204
18F-FDG PET/CT in the assessment of carcinoma of unknown primary origin 201
Preclinical evaluation of KIT/PDGFRA and mTOR inhibitors in gastrointestinal stromal tumors using small animal FDG PET. 197
The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas 196
11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy 191
Comparison between (68)Ga-DOTA-NOC and (18)F-DOPA PET for the detection of gastro-entero-pancreatic and lung neuro-endocrine tumours. 190
Contrast enhanced MRI and (18)F-FDG PET-CT in the assessment of multiple myeloma: a comparison of results in different phases of the disease 189
Comparison of 18F-FACBC and 11C-choline PET/CT in patients with radically treated prostate cancer and biochemical relapse: preliminary results 188
18F-FACBC PET/CT in comparison to 11c-choline for the detection of prostate cancer relapse after radical prostatectomy: A perspective study in 50 patients 186
The additional diagnostic value of contemporary evaluation of FDG PET/CT scan and contrast enhanced CT imaging both acquired by a last generation PET/CT system in oncologic patients. 184
First case of 18F-FACBC PET/CT-guided salvage radiotherapy for local relapse after radical prostatectomy with negative 11C-Choline PET/CT and multiparametric MRI: New imaging techniques may improve patient selection. 182
18F-Fluciclovine PET/CT for the Detection of Prostate Cancer Relapse A Comparison to 11C-Choline PET/CT 181
68Ga-citrate PET/CT for evaluating patients with infections of the bone: preliminary results. 175
TOMOGRAFIA AD EMISSIONE DI POSITRONI CON 11-C-COLINA INTEGRATO A UN SISTEMA TC (11-C-CHOLINE-PET/TC) E RISONANZA MAGNETICA DI SPETTROSCOPIA DEL PROTONE (1-H-MRSI) NELLA DIAGNOSI DI NEOPLASIA PROSTATICA: STUDIO COMPARATIVO 174
Cancer-associated stroma affects FDG uptake in experimental carcinomas. Implications for FDG-PET delineation of radiotherapy target. 172
Evaluation of unusual neuroendocrine tumours by means of (68)Ga-DOTA-NOC PET. 171
Late FDG PET normalization after radioimmunotherapy in a patient with non-Hodgkin lymphoma. 168
11C-acetate PET for early prediction of sunitinib response in metastatic renal cell carcinoma. 167
Usefulness of 124I PET/CT imaging to predict absorbed doses in patients affected by metastatic thyroid cancer and treated with 131I. 166
Evaluation of Modified PEG-Anilinoquinazoline Derivatives as Potential Agents for EGFR Imaging in Cancer by Small Animal PET. 166
The Possible Role of PET Imaging Toward Individualized Management of Bone and Soft Tissue Malignancies. 165
18F-FDG PET/CT in myeloma with presumed solitary plasmocytoma of bone. 164
Early relapse in a patient with Hodgkin's disease and negative interim FDG-PET. 164
Conventional and novel PET tracers for imaging in oncology in the era of molecular therapy. Review 163
(18)F-FDG PET in Pediatric Lymphomas: A Comparison with Conventional Imaging. 160
FUNCTIONAL AND HISTOPATHOLOGICAL IMPROVEMENT OF THE POST-INFARCTED RAT HEART UPON MYOBLAST CELL GRAFTING AND RELAXIN THERAPY. 159
Efficacy of PHA-848125, a cyclin-dependent kinase inhibitor, on the K-Ras(G12D)LA2 lung adenocarcinoma transgenic mouse model: evaluation by multimodality imaging. 158
Incidental finding of an (11)C-choline PET-positive solitary plasmacytoma lesion. 156
Role of (11)C-choline PET/CT in the re-staging of prostate cancer patients with biochemical relapse and negative results at bone scintigraphy 154
Clinical significance of axillary findings in patients with lymphoma during follow-up with 18F-fluorodeoxyglucose-PET. 153
18F-DOPA PET/CT in neuroblastoma: comparison of conventional imaging with CT/MR. 151
Detection of liver lesions during 11C-Choline PET/CT in relapsing prostate cancer patients 151
The role of (18)F-FDG PET/CT in detecting metastatic deposits of recurrent medullary thyroid carcinoma: A prospective study. 149
Comparison of 18F-dopa PET/CT and 123I-MIBG scintigraphy in stage 3 and 4 neuroblastoma: a pilot study. 149
Molecular Imaging of Neuroblastoma Progression in TH-MYCN Transgenic Mice 145
Is there a role for 11C-choline PET/CT in the early detection of metastatic disease in surgically treated prostate cancer patients with a mild PSA increase <1.5 ng/ml? 144
Small animal PET for the evaluation of an animal model of genital infection 144
I-123 MIBG scintigraphy and 68Ga-DOTANOC PET/CT negative but F-18 DOPA PET/CT positive pheochromocytoma: a case report. 142
Imaging with (11)Carbon labelled PET tracers. 141
Ga-68-DOTA-peptides versus F-18-DOPA PET for the assessment of NET patients 140
FDG-PET and PET/CT for evaluating soft tissue sarcomas 140
Small animal PET in oncology: the road from bench to bedside. 134
PET Tracers Beyond FDG in Prostate Cancer. 133
Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation 133
Contouring carcinomas by FDG-PET: is the role of tumor biology underestimated? In regard to MacManus et al. (Int J Radiat Oncol Biol Phys 2008;71:2-4). 131
Is 68Ga-DOTA-NOC PET/CT indicated in patients with clinical, biochemical or radiological suspicion of neuroendocrine tumour? 129
Feasibility of carbidopa premedication in pediatric patients: a pilot study. 128
Present and future of PET and PET/CT in gynaecologic malignancies. 127
Positron-emission tomography in gynaecologic malignancies. 127
PET/CT imaging for evaluating response to therapy in castration-resistant prostate cancer. 125
Evaluation of Prostate Cancer with Radiolabeled Amino Acid Analogs. 124
Dall'imaging anatomico al metabolico (neoplasie del polmone) 123
PET/TC e TC nella stadiazione pre- e post-chemioterapia neoadiuvante in pazienti con carcinoma ovarico ad alto grado di malignità. 123
The Value of 18F-FDG PET/CT after Autologous Stem Cell Transplantation (ASCT) in Patients Affected by Multiple Myeloma (MM): Experience With 77 Patients 121
Nutraceuticals & gut: phytosterol & ulcerative colits. 118
Linfomi. Imaging metabolico 115
Preclinical studies with small animal PET 113
PET/CT in the management and prognosis of pancreatic exocrine tumors. 113
Positron emission tomography for the evaluation of soft-tissue sarcomas and bone sarcomas. 112
Follow-up delle neoplasie polmonari 110
PET-CT: Rare Findings and Diseases 110
Follow-up / Corso monotematico 109
Influence of trigger PSA and PSA kinetics on 11C-Choline PET/CT detection rate in patients with biochemical relapse after radical prostatectomy. 109
Dall'imaging anatomico al metabolico/ Corso monotematico 107
The clinical use of PET with (11)C-acetate. 89
Linfomi: imaging metabolico/ Corso monotematico 88
PET/CT in Oncology 85
Totale 12.416
Salva come PNG Salva come JPEG
Categoria #
all - tutte 32.993
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.993
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021387 0 0 0 0 0 0 0 0 0 0 0 387
2021/20221.719 429 58 103 144 127 83 29 95 47 86 295 223
2022/20231.539 156 210 93 241 95 116 47 74 240 66 119 82
2023/2024338 38 73 16 31 31 59 20 11 19 18 9 13
2024/20251.337 38 280 136 96 265 74 102 23 12 67 31 213
2025/20263.015 176 243 286 176 371 201 276 87 671 257 168 103
Totale 12.416